Calcium-regulated transcriptional pathways in the normal and pathologic heart

IUBMB Life

Volumn 63, Issue 10, 2011, Pages 847-855

  Zarain Herzberg, Angel ^a   Fragoso Medina, Jorge ^a   Estrada Avilés, Rafael ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

calcium; gene expression; heart; MEF2; NFAT; signaling; transcription

Indexed keywords

ADENOVIRUS VECTOR; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALSEQUESTRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MYOCYTE ENHANCER FACTOR 2; PROTEIN SERCA2A; RANOLAZINE; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM SIGNALING; CARDIOVASCULAR GENE THERAPY; CONFERENCE PAPER; DIASTOLIC DYSFUNCTION; DOWN REGULATION; DRUG SAFETY; ENDOPLASMIC RETICULUM STRESS; EXCITATION CONTRACTION COUPLING; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUDDEN DEATH; TRANSCRIPTION REGULATION; UPREGULATION;

CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CALSEQUESTRIN; CARDIOMEGALY; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MADS DOMAIN PROTEINS; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; NFATC TRANSCRIPTION FACTORS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 80053296633     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.545     Document Type: Conference Paper

References (64)

1. Bers, D. M., (2002) Cardiac excitation-contraction coupling. Nature 415, 198-205. (Pubitemid 34059525)
2. Bers, D. M., (2008) Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70, 23-49. (Pubitemid 351738170)
3. Yano, K., and, Zarain-Herzberg, A., (1994) Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol. Cell. Biochem. 135, 61-70. (Pubitemid 24279108)
4. Prasad, A. M., and, Inesi, G., (2011) Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 300, H173-H180.
5. Reyes-Juarez, J. L., and, Zarain-Herzberg, A., (2006) [Function and role of the sarcoplasmic reticulum in heart disease]. Arch. Cardiol. Mex. 76 (Suppl 4), S18-S32.
6. Zarain-Herzberg, A., (2006) Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart. Can. J. Physiol. Pharmacol. 84, 509-521. (Pubitemid 44350525)
7. Alpert, N. R., Brosseau, C., Federico, A., Krenz, M., Robbins, J., et al. (2002) Molecular mechanics of mouse cardiac myosin isoforms. Am. J. Physiol. Heart Circ. Physiol. 283, H1446-H1454.
8. Vannier, C., Chevassus, H., and, Vassort, G., (1996) Ca-dependence of isometric force kinetics in single skinned ventricular cardiomyocytes from rats. Cardiovasc. Res. 32, 580-586. (Pubitemid 26288604)
9. Baker, A. J., Figueredo, V. M., Keung, E. C., and, Camacho, S. A., (1998) Ca2+ regulates the kinetics of tension development in intact cardiac muscle. Am. J. Physiol. 275, H744-H750.
10. Palmer, S., and, Kentish, J. C., (1998) Roles of Ca2+ and crossbridge kinetics in determining the maximum rates of Ca2+ activation and relaxation in rat and guinea pig skinned trabeculae. Circ. Res. 83, 179-186. (Pubitemid 28354462)
11. Teucher, N., Prestle, J., Seidler, T., Currie, S., Elliott, E. B., et al. (2004) Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening. Circulation 110, 3553-3559. (Pubitemid 39612570)
12. Bassani, J. W., Qi, M., Samarel, A. M., and, Bers, D. M., (1994) Contractile arrest increases sarcoplasmic reticulum calcium uptake and SERCA2 gene expression in cultured neonatal rat heart cells. Circ. Res. 74, 991-997. (Pubitemid 24121603)
13. Kaprielian, R., del Monte, F., and, Hajjar, R. J., (2002) Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer. Basic Res. Cardiol. 97 (Suppl 1), I136-I145.
14. Soltis, A. R., and, Saucerman, J. J., (2010) Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling. Biophys. J. 99, 2038-2047.
15. Hoshijima, M., Knoll, R., Pashmforoush, M., and, Chien, K., (2006) Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. J. Am. Coll. Cardiol. 48, A15-A23. (Pubitemid 44755024)
16. Braunwald, E., and, Bristow, M. R., (2000) Congestive heart failure: fifty years of progress. Circulation 102, IV14-IV23.
17. Ai, X., Curran, J. W., Shannon, T. R., Bers, D. M., and, Pogwizd, S. M., (2005) Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ. Res. 97, 1314-1322.
18. van Oort, R. J., McCauley, M. D., Dixit, S. S., Pereira, L., Yang, Y., et al. (2010) Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 122, 2669-2679.
19. Belevych, A. E., Terentyev, D., Terentyeva, R., Nishijima, Y., Sridhar, A., et al. (2011) The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc. Res. 90, 493-502.
20. Undrovinas, N. A., Maltsev, V. A., Belardinelli, L., Sabbah, H. N., and, Undrovinas, A., (2010) Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J. Physiol. Sci. 60, 245-257.
21. Sossalla, S., Wagner, S., Rasenack, E. C., Ruff, H., Weber, S. L., et al. (2008) Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J. Mol. Cell. Cardiol. 45, 32-43.
22. Diedrichs, H., Hagemeister, J., Chi, M., Boelck, B., Muller-Ehmsen, J., et al. (2007) Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium. J. Int. Med. Res. 35, 803-818. (Pubitemid 350238414)
23. Schaeffer, P. J., Desantiago, J., Yang, J., Flagg, T. P., Kovacs, A., et al. (2009) Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 297, H744-H750.
24. Sanna, B., Bueno, O. F., Dai, Y. S., Wilkins, B. J., and, Molkentin, J. D., (2005) Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol. Cell. Biol. 25, 865-878. (Pubitemid 40165796)
25. Colella, M., Grisan, F., Robert, V., Turner, J. D., Thomas, A. P., et al. (2008) Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc. Natl. Acad. Sci. USA 105, 2859-2864. (Pubitemid 351723634)
26. McKinsey, T. A., Zhang, C. L., and, Olson, E. N., (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27, 40-47. (Pubitemid 34131624)
27. Black, B. L., and, Olson, E. N., (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell. Dev. Biol. 14, 167-196. (Pubitemid 29001453)
28. el Azzouzi, H., van Oort, R. J., van der Nagel, R., Sluiter, W., Bergmann, M. W., et al. (2010) MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload. Eur. J. Heart Fail. 12, 4-12.
29. van Oort, R. J., van Rooij, E., Bourajjaj, M., Schimmel, J., Jansen, M. A., et al. (2006) MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114, 298-308. (Pubitemid 44297096)
30. Gordon, J. W., Pagiatakis, C., Salma, J., Du, M., Andreucci, J. J., et al. (2009) Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J. Biol. Chem. 284, 19027-19042.
31. Backs, J., Backs, T., Bezprozvannaya, S., McKinsey, T. A., and, Olson, E. N., (2008) Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell. Biol. 28, 3437-3445. (Pubitemid 351657105)
32. Berger, I., Bieniossek, C., Schaffitzel, C., Hassler, M., Santelli, E., et al. (2003) Direct interaction of Ca2+/calmodulin inhibits histone deacetylase 5 repressor core binding to myocyte enhancer factor 2. J. Biol. Chem. 278, 17625-17635. (Pubitemid 36799364)
33. Zhang, T., Kohlhaas, M., Backs, J., Mishra, S., Phillips, W., et al. (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J. Biol. Chem. 282, 35078-35087. (Pubitemid 350232479)
34. MacDonnell, S. M., Weisser-Thomas, J., Kubo, H., Hanscome, M., Liu, Q., et al. (2009) CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. Circ. Res. 105, 316-325.
35. Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., et al. (2000) CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Investig. 105, 1395-1406. (Pubitemid 30322405)
36. Kolodziejczyk, S. M., Wang, L., Balazsi, K., DeRepentigny, Y., Kothary, R., et al. (1999) MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 9, 1203-1206. (Pubitemid 29527110)
37. Zhang, Z. Y., Liu, X. H., Hu, W. C., Rong, F., and, Wu, X. D., (2010) The calcineurin-myocyte enhancer factor 2c pathway mediates cardiac hypertrophy induced by endoplasmic reticulum stress in neonatal rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 298, H744-H750.
38. Metrich, M., Laurent, A. C., Breckler, M., Duquesnes, N., Hmitou, I., et al. (2010) Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell. Signal. 22, 1459-1468.
39. Zobel, C., Rana, O. R., Saygili, E., Bolck, B., Diedrichs, H., et al. (2007) Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy. Cardiology 107, 281-290. (Pubitemid 46788245)
40. van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103, 18255-18260. (Pubitemid 44871645)
41. Ikeda, S., He, A., Kong, S. W., Lu, J., Bejar, R., et al. (2009) MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell. Biol. 29, 2193-2204.
42. da Costa Martins, P. A., Salic, K., Gladka, M. M., Armand, A. S., Leptidis, S., et al. (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol. 12, 1220-1227.
43. Guo, X., Williams, J. G., Schug, T. T., and, Li, X., (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285, 13223-13232.
44. Sundaresan, N. R., Pillai, V. B., and, Gupta, M. P., (2011) Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. J. Mol. Cell. Cardiol.
45. Putt, M. E., Hannenhalli, S., Lu, Y., Haines, P., Chandrupatla, H. R., et al. (2009) Evidence for coregulation of myocardial gene expression by MEF2 and NFAT in human heart failure. Circ. Cardiovasc. Genet 2, 212-219.
46. Adachi, Y., Yamamoto, K., Okada, T., Yoshida, H., Harada, A., et al. (2008) ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct. Funct. 33, 75-89. (Pubitemid 351860903)
47. Li, M., Baumeister, P., Roy, B., Phan, T., Foti, D., et al. (2000) ATF6 as a transcription activator of the endoplasmic reticulum stress element: thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol. Cell. Biol. 20, 5096-5106. (Pubitemid 30431563)
48. Thuerauf, D. J., Hoover, H., Meller, J., Hernandez, J., Su, L., et al. (2001) Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J. Biol. Chem. 276, 48309-48317.
49. Belmont, P. J., Tadimalla, A., Chen, W. J., Martindale, J. J., Thuerauf, D. J., et al. (2008) Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene. J. Biol. Chem. 283, 14012-14021.
50. Vlasblom, R., Muller, A., Musters, R. J., Zuidwijk, M. J., Van Hardeveld, C., et al. (2004) Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc. Res. 63, 537-544. (Pubitemid 38970198)
51. Beard, N. A., Wei, L., and, Dulhunty, A. F., (2009) Control of muscleryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen. Clin. Exp. Pharmacol. Physiol. 36, 340-345.
52. Reyes-Juarez, J. L., Juarez-Rubi, R., Rodriguez, G., and, Zarain-Herzberg, A., (2007) Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes. J. Biol. Chem. 282, 35554-35563. (Pubitemid 350277093)
53. Kasneci, A., Kemeny-Suss, N. M., Komarova, S. V., and, Chalifour, L. E., (2009) Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc. Res. 81, 695-702.
54. Zarain-Herzberg, A., Rupp, H., Elimban, V., and, Dhalla, N. S., (1996) Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB, J. 10, 1303-1309. (Pubitemid 26307516)
55. Zarain-Herzberg, A., and, Rupp, H., (2002) Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target. Expert Opin. Investig. Drugs 11, 345-356. (Pubitemid 34213389)
56. Gianni, D., Chan, J., Gwathmey, J., del Monte, F., and, Hajjar, R., (2005) SERCA2a in heart failure: role and therapeutic prospects. J. Bioenerg. Biomembr. 37, 375-380. (Pubitemid 43725161)
57. Miyamoto, M. I., del Monte, F., Schmidt, U., DiSalvo, T. S., Kang, Z. B., et al. (2000) Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. USA 97, 793-798. (Pubitemid 30070389)
58. Beeri, R., Chaput, M., Guerrero, J. L., Kawase, Y., Yosefy, C., et al. (2010) Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circulation: Heart Fail. 3, 627-634.
59. Molina, E. J., Gupta, D., Palma, J., Gaughan, J. P., and, Macha, M., (2010) Right ventricular beneficial effects of intracoronary SERCA2a gene transfer in an experimental model of heart failure. Folia Biol. (Praha) 56, 1-8.
60. Mariani, J. A., Smolic, A., Preovolos, A., Byrne, M. J., Power, J. M., et al. (2011) Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure. Eur. J. Heart Fail. 13, 247-253.
61. Wright, M. J., Wightman, L. M., Latchman, D. S., and, Marber, M. S., (2001) In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther. 8, 1833-1839. (Pubitemid 34141489)
62. Hajjar, R. J., Zsebo, K., Deckelbaum, L., Thompson, C., Rudy, J., et al. (2008) Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J. Card. Fail. 14, 355-367. (Pubitemid 351756538)
63. Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., et al. (2009) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J. Card. Fail. 15, 171-181.
64. Pinz, I., Tian, R., Belke, D., Swanson, E., Dillmann, W., et al. (2011) Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a. J. Biol. Chem. 286, 10163-10168.